The observed metabolic differences between ERG-positive and ERG-negative PC indicate that the increase in β-oxidation and purine metabolism often reported for PC could be mainly attributed to TMPRSS2-ERG-negative tumors. Here, TMPRSS2 is linked to pachyonychia congenita.